Axsome Therapeutics Hosts SYMBRAVO® FDA Approval Virtual Investor Event with Expert Thought Leader
Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, will ...
Becker's Hospital Review19h
FDA warns GLP-1 compounder over safety rules
The FDA issued a warning letter to ProRx, a compounding facility in Exton, Penn., after an inspection raised serious concerns regarding the safety and compliance of its drug products. The facility, ...
Big News Network.com14d
Bausch Health Statement on Selection of XIFAXAN(R) (rifaximin) for Inflation Reduction Act's Medicare Negotiation Program
LAVAL, QC / ACCESS Newswire / January 17, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals, today acknowledged that the Centers for ...
UPI16d
New FDA proposal would put 'front-of-package' nutrition labels on food products
Jan. 14 (UPI) --The U.S. Food and Drug Administration hopes "front-of-package" labeling will better improve the American population's health, the FDA announced. "Food should be a vehicle for ...
FiercePharma27d
Novo asks FDA to restrict Victoza compounding amid GLP-1 outsourcing row
sales of nearly 8.67 billion Danish kroner (around $1.2 billion). Meanwhile, generic drug makers have already sought out to capitalize on liraglutide’s success. Teva launched an authorized ...
Hosted on MSN28d
FDA Issues 4th Oyster Warning In 18 Days: Latest Advisory In Washington Over Norovirus Outbreaks
The Food and Drug Administration issued an oyster recall Thursday—its fourth in three weeks, after hundreds have been left sick—warning against the eating of certain oysters harvested in ...
Indiatimes29d
Over 250 medicines to cost more from January 1 in the U.S; is your critical drug in the list? Check here
On January 1, pharmaceutical companies will also lower some of their prices. The list price of Merck & Co.'s heavily discounted diabetes medications Januvia and Janumet will be lowered "to align the ...
gastroenterologyadvisor29d
FDA Says Shortage of GLP-1 Tirzepatide Is Over
HealthDay News — The U.S. Food and Drug Administration re-issued a decision first made by the agency in October that a shortage of the diabetes/weight-loss medication tirzepatide is over. Tirzepatide ...
thehealthy29d
FDA Announcement: The First Generic GLP-1 Shot Has Just Been Approved
Many diabetes patients have experienced lowered drug costs in recent years, thanks to policies that have capped the price of diabetes prescriptions. For patients who have been paying for Ozempic or ...
Food Dive29d
GLP-1 drug use cuts grocery spending by 6%, study finds
As more consumers take GLP-1 drugs such as Ozempic and Wegovy, changing appetites are squeezing sales for some food and beverage items. The Cornell and Numerator study noted that a 6% decline in ...
Reuters1mon
FDA approves injectable version of Bristol Myers Squibb's cancer drug Opdivo
Opdivo is part of a class of drugs called PD-1 inhibitors, which enhance the immune ... as maintenance therapy or in combination with chemotherapy. The drug will be available in early January ...